News & Analysis as of

Attorney General Antitrust Violations

Health Care Compliance Association (HCCA)

Deputy Assistant Attorney General Richard A. Powers remarks on the state of criminal antitrust enforcement

Compliance Today (April 2020) The following are prepared remarks by Deputy Assistant Attorney General Richard A. Powers delivered February 7, 2020. He discussed recent litigation and enforcement actions; however, the...more

Cozen O'Connor

COVID-19-Related Price Gouging | COVID-19-Related Fake Medicines | COVID-19-Related Antitrust Review Speed-Up

Cozen O'Connor on

COVID-19- Attorneys General Step Up Enforcement Efforts Against Price Gouging- •AGs across the country are taking steps to protect the public from price gouging by sellers capitalizing on the COVID-19 pandemic. ...more

Cozen O'Connor

The State AG Report Weekly Update October 2018 #3

Cozen O'Connor on

2018 State AG Elections- Cozen O’Connor’s State AG Election Tracker Updates 2018 Election Prediction for Nevada Attorney General Race- With 19 days to go before election day, Cozen O’Connor’s State AG Election Tracker has...more

Cozen O'Connor

The State AG Report Weekly Update April 2018 #4

Cozen O'Connor on

Antitrust- Texas Attorney General Reaches Settlement with Dental Supply Distributor Over Alleged Anticompetitive Conduct- Texas Attorney General Ken Paxton settled with dental supply distributor Patterson Companies,...more

Mintz

Washington State AG Alleges Price Fixing and Sues to Break Up Rapidly Expanding Health System

Mintz on

After five years of growth through a series of acquisitions, the Washington State Attorney General’s office filed a lawsuit to thwart and unwind the most recent expansion efforts of Franciscan Health System (“CHI Franciscan”)...more

Skadden, Arps, Slate, Meagher & Flom LLP

Cross Border Investigations Update - July 2017

This issue of Skadden’s semiannual Cross-Border Investigations Update takes a close look at recent cases and enforcement trends, including the new Criminal Finances Act 2017, increased regulatory scrutiny of Chinese companies...more

Mintz

Antitrust Suit Against Michigan Hospital Moves Forward As Both Sides Denied Summary Judgment

Mintz on

A federal district court denied summary judgment motions brought by both sides in the government’s antitrust suit against a Michigan hospital alleging an agreement not to compete in violation of Section 1 of the Sherman Act....more

Perkins Coie

Federal and State Antitrust Enforcement Takeaways From the 2017 ABA Antitrust Law Spring Meeting

Perkins Coie on

The American Bar Association’s 65th Antitrust Law Spring Meeting held at the end of March included a number of sessions with representatives from federal and state antitrust enforcement agencies. In this first of a three-part...more

Patterson Belknap Webb & Tyler LLP

DOJ and Stage AG Investigations Into Generic Pricing Lead to Suits Against Manufacturers and Employees

As we have previously reported, (click, here, here, here, and here to read more), generic drug manufacturers have recently come under intense scrutiny from state and federal regulators for their price hikes. Last week, the...more

Foley & Lardner LLP

Three Dozen States Sue Makers of Opioid Addiction Treatment Medications for Antitrust

Foley & Lardner LLP on

With opioid abuse continuing to dominate national headlines, manufacturers of opioid overdose medications are facing intense scrutiny over pricing practices that threaten (or those perceived as threatening) public...more

McDermott Will & Emery

Maryland AG Challenges Resale Price Maintenance Agreement

McDermott Will & Emery on

On February 29, 2016, the Attorney General of Maryland filed a complaint alleging that Johnson & Johnson Vision Care, Inc. (Johnson & Johnson) violated the Maryland state antitrust law by entering into an agreement with a...more

Patterson Belknap Webb & Tyler LLP

Second Circuit Affirms Preliminary Injunction in People of the State of New York v. Actavis PLC

We’ve previously covered the New York State Attorney General’s (“NYS AG”) lawsuit against Actavis PLC and Forest Laboratories seeking to prevent them from discontinuing sales of the Forest drug Namenda IR, which is used to...more

12 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide